Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19
Journal of Immunology Research · 2025
DOI: 10.1155/jimr/9743866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Diptee Trimbake und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dengue and Chikungunya, Indian Council of Medical Research-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, India. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Immunologic Memory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Research on long‐term follow‐up in individuals who have recovered from coronavirus disease‐19 (COVID‐19) would yield insights regarding their immunity status and identify those who need booster vaccinations. This study evaluated the longevity of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐specific cellular and humoral memory responses, as well as T cell effector functionalities, at 1–2 months ( n = 40), 8–9 months ( n = 40), and 12 months/1 year ( n = 27) following recovery from SARS‐CoV‐2 infection. CTL response by enzyme‐linked immunospot (ELISPOT); levels of cytokine by Bio‐Plex, natural killer (NK), CD4+ helper, and CD8+ cytotoxic T cell functionalities using flow cytometry; anti‐SARS‐CoV‐2 IgG by ELISA; and levels of neutralizing antibodies (NAbs) by surrogate virus NAb assay were assessed. The levels of SARS‐CoV‐2‐specific IgG and NAb at 1–2 and 8−9 months postrecovery were hand in hand and appeared declining. SARS‐CoV‐2‐specific B, memory B and plasma cells, and T cells sustained up to 8–9 months. Increased expression of CD107a/IFN‐γ by NK cells and cytotoxic T cells at 8–9 months could be indicative of SARS‐CoV‐2‐specific effector functions. Recovered individuals with positive and negative IgG antibody status displayed T cell response up to 1 year and 8–9 months, respectively, emphasizing the durabilty of effector immunity up to 8–9 months regardless of IgG antibody status. Overall, the recovered individuals exhibited robust immunological memory, sustained T cell response with effector functionality against SARS‐CoV‐2 that persists for at least 8–9 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dengue and Chikungunya, Indian Council of Medical Research-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, India.
- Department of Medicine, Pimpri Chinchwad Municipal Corporation, Pimpri, Pune 411018, Maharashtra, India.
ORCID-Profile: Anuradha S Tripathy
Zitieren
APA
Trimbake, D., Singh, D., K, Y. G., Babar, P., S, V. D., & Tripathy, A. S. (2025). Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19. Journal of Immunology Research. https://doi.org/10.1155/jimr/9743866
Vancouver
Trimbake D, Singh D, K YG, Babar P, S VD, Tripathy AS. Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19. Journal of Immunology Research. 2025. doi:10.1155/jimr/9743866
BibTeX
@article{Trimbake2025,
author = {Trimbake, Diptee and Singh, Dharmendra and K, Yogesh Gurav and Babar, Prasad and S, Varsha Dange and Tripathy, Anuradha S},
title = {Durability of Functional SARS‐CoV‐2‐Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID‐19},
journal = {Journal of Immunology Research},
year = {2025},
doi = {10.1155/jimr/9743866}
}
EUVIMED